Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MUHAMMAD J HABIB

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1871856351
CMS profile
39980
Location
NOBLESVILLE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,631.98

129 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,544.74 127
Education $87.24 2

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MUHAMMAD J HABIB

NPI 1871856351 · CMS profile ID 39980

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

NOBLESVILLE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1871856351?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MUHAMMAD J HABIB, NPI 1871856351, CMS profile ID 39980. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1871856351?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MUHAMMAD J HABIB, NPI 1871856351, CMS profile ID 39980. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1871856351?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MUHAMMAD J HABIB, NPI 1871856351, CMS profile ID 39980, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1871856351?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

129 matching records · $2,631.98 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 129 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 129.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $25.7308/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206422805 CMS
Grifols USA, LLC $23.0808/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249596265 CMS
GlaxoSmithKline, LLC. $4.5808/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191806305 CMS
Lilly USA, LLC $16.6807/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186823410 CMS
GlaxoSmithKline, LLC. $3.2607/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191029970 CMS
AstraZeneca Pharmaceuticals LP $18.4207/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207281867 CMS
GENZYME CORPORATION $30.5107/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233448429 CMS
SANOFI-AVENTIS U.S. LLC $78.9907/29/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1233448425 CMS
GlaxoSmithKline, LLC. $20.8307/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191443610 CMS
GlaxoSmithKline, LLC. $20.0207/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191838403 CMS
GENZYME CORPORATION $19.7407/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233448433 CMS
Paratek Pharmaceuticals, Inc. $17.5707/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181747428 CMS
AstraZeneca Pharmaceuticals LP $14.6407/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206169526 CMS
ABBVIE INC. $30.8807/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201986051 CMS
Insmed, Inc. $18.5507/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186314587 CMS
GlaxoSmithKline, LLC. $17.2107/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191164180 CMS
Insmed, Inc. $24.1306/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186311416 CMS
AstraZeneca Pharmaceuticals LP $25.0606/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206165464 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.5806/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223853745 CMS
GlaxoSmithKline, LLC. $2.9006/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190690990 CMS
GlaxoSmithKline, LLC. $1.2206/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191216345 CMS
GlaxoSmithKline, LLC. $15.7406/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190496568 CMS
Regeneron Healthcare Solutions, Inc. $4.4206/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212935594 CMS
AstraZeneca Pharmaceuticals LP $17.5606/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206868640 CMS
GENZYME CORPORATION $2.7506/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233448435 CMS
Viatris Specialty LLC $20.8706/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238506387 CMS
United Therapeutics Corporation $29.0905/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242554848 CMS
ABBVIE INC. $22.3905/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201986049 CMS
Amgen Inc. $15.8305/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228434582 CMS
GlaxoSmithKline, LLC. $7.1105/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190864746 CMS
JAZZ PHARMACEUTICALS INC. $34.2005/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234318350 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.9605/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222918491 CMS
GENZYME CORPORATION $2.0005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233448409 CMS
GENZYME CORPORATION $8.2505/09/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1233448403 CMS
AstraZeneca Pharmaceuticals LP $34.2904/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206379750 CMS
Viatris Specialty LLC $16.7004/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238501269 CMS
Actelion Pharmaceuticals US, Inc. $19.8604/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174224025 CMS
GlaxoSmithKline, LLC. $21.0504/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190798836 CMS
Fisher & Paykel Healthcare Inc $21.5304/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244151265 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.5804/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223878714 CMS
JAZZ PHARMACEUTICALS INC. $15.1904/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234343865 CMS
AstraZeneca Pharmaceuticals LP $20.7304/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206669648 CMS
Regeneron Healthcare Solutions, Inc. $33.2404/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212935592 CMS
AstraZeneca Pharmaceuticals LP $10.9604/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206851618 CMS
GENZYME CORPORATION $18.3504/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233448397 CMS
GlaxoSmithKline, LLC. $20.3504/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190441132 CMS
Paratek Pharmaceuticals, Inc. $16.4004/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181747426 CMS
United Therapeutics Corporation $27.2804/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242548398 CMS
GlaxoSmithKline, LLC. $7.0503/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190779421 CMS
Electromed, Inc. $17.2303/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224590409 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,008.69 78
PY2020 $1,549.40 88
PY2021 $2,584.47 157
PY2022 $2,267.06 125
PY2023 $2,975.67 144
PY2024 $2,517.83 124
PY2025 $2,631.98 129

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $119,628.45 4
PY2024 Principal investigator $99,818.45 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $17,113.60 11/21/2025 Non-covered Recipient Entity
DUNES CLINICAL RESEARCH LLC
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease COPD No dispute reported 06/30/2026 1185546523
Principal investigator 1 SANOFI US SERVICES INC. $14,327.00 10/30/2025 Non-covered Recipient Entity
Ethos Indy Research Llc
A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype No dispute reported 06/30/2026 1226103892
Principal investigator 1 AstraZeneca Pharmaceuticals LP $13,450.00 06/04/2025 Non-covered Recipient Entity
DUNES CLINICAL RESEARCH LLC
A Phase 2 randomized double blind placebo controlled dose regimen range finding study to assess efficacy and safety of subcutaneous tozorakimab in adult participants with uncontrolled asthma on medium to high dose inhaled corticosteroids No dispute reported 06/30/2026 1185546525
Principal investigator 1 AstraZeneca Pharmaceuticals LP $74,737.85 01/10/2025 Non-covered Recipient Entity
DUNES CLINICAL RESEARCH LLC
A Phase 4 Multicenter Randomized Double blind Parallel Group Placebo controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK) No dispute reported 06/30/2026 1185546521